6801 - 6825 of 9033 Results
Title
Year
-
OPENTitle: Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advancesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 101End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00716-zBest OA location URL: https://www.nature.com/articles/s41531-024-00716-z.pdfCitation Count: 12
-
OPENTitle: Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 1Start Page: 1End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20170802Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/1/1/694077/bcj-2017-0802.pdfCitation Count: 166
-
OPENTitle: Feasibility of Virtual Research Visits in Fox Trial FinderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 505End Page: 515Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.3233/jpd-150549Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150549?id=journal-of-parkinsons-disease%2Fjpd150549Citation Count: 64
- Oxidative Damage in Parkinson's Disease2005RESTRICTEDTitle: Oxidative Damage in Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: SAGE PublicationsVol: 7Issue #: 5-6Start Page: 627End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2005.7.627Citation Count: 27
- Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's disease2016RESTRICTEDTitle: Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 8Start Page: 1192End Page: 1202Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26614Citation Count: 126
-
OPENTitle: The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and humanJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 11Start Page: 1861End Page: 1883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20180248Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/11/1861/691623/bcj-2018-0248.pdfCitation Count: 218
-
OPENTitle: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 15End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00451-xBest OA location URL: https://www.nature.com/articles/s41531-023-00451-x.pdfCitation Count: 12
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 2381468320978407End Page: 2381468320978407Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 23
-
OPENTitle: Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 115Issue #:Start Page: 106713End Page: 106713Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2022.106713Best OA location URL: https://doi.org/10.1016/j.cct.2022.106713Citation Count: 20
-
OPENTitle: Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s diseaseJournal Name: Journal of Medical GeneticsPublisher: BMJVol: 57Issue #: 5Start Page: 331End Page: 338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jmedgenet-2019-106283Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8474559Citation Count: 71
-
OPENTitle: Evaluation of a Mitochondrial Polygenic Score for Parkinson's Disease Across AncestriesJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 9Start Page: 2015End Page: 2018Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30285Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30285Citation Count: 2
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021RESTRICTEDTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #: Autumn 123Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.36866/123.32Citation Count: 0
-
OPENTitle: New diagnostic and staging framework applied to established PD in the BioFIND cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 151End Page: 151Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-00992-3Best OA location URL: https://www.nature.com/articles/s41531-025-00992-3.pdfCitation Count: 1
-
OPENTitle: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 7Start Page: 879End Page: 880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975Citation Count: 0
-
OPENTitle: Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examinationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 94End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00360-5Best OA location URL: https://www.nature.com/articles/s41531-022-00360-5.pdfCitation Count: 5
-
OPENTitle: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 282End Page: 288Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27232Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27232Citation Count: 148
-
OPENTitle: Recruitment for Remote Decentralized Studies in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 371End Page: 380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212935Best OA location URL: https://escholarship.org/uc/item/0k98f47rCitation Count: 20
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: http://doi.org/10.1002/mds.26170Citation Count: 307
-
OPENTitle: Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 178End Page: 178Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00789-wBest OA location URL: https://www.nature.com/articles/s41531-024-00789-w.pdfCitation Count: 34
-
OPENTitle: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 3Start Page: 312End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2773698/jamaneurology_simuni_2020_oi_200091_1614894403.37383.pdfCitation Count: 143
-
OPENTitle: Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change MeasuresJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 4Start Page: 665End Page: 679Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181518Best OA location URL: https://escholarship.org/uc/item/2w68g45qCitation Count: 25
-
OPENTitle: Parkinson’S Disease is Ready for Precision MedicineJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 13Issue #: 5Start Page: 405End Page: 407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0052Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0052Citation Count: 7
-
OPENTitle: Genetic Testing for Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 1Start Page: 69End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8101316Citation Count: 39
-
OPENTitle: Beyond Alzheimer’s disease—translating biomarker insights across CNS diseasesJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 17Issue #: 823Start Page: eadr2511End Page: eadr2511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adr2511Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13162155/Citation Count: 1
-
OPENTitle: Reply to: “Refutation of the αSyn ‐ SAA ‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD ‐ ISS] )”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 8Start Page: 1746End Page: 1747Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30272Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30272Citation Count: 1